Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events?

EuroIntervention. 2015 Feb;10(10):1139-42. doi: 10.4244/EIJY14M11_09.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Absorbable Implants*
  • Acute Coronary Syndrome / surgery*
  • Angina Pectoris / surgery*
  • Antineoplastic Agents / therapeutic use*
  • Coronary Artery Disease / surgery*
  • Drug-Eluting Stents*
  • Everolimus / therapeutic use*
  • Female
  • Humans
  • Male
  • Myocardial Infarction / surgery*
  • Tissue Scaffolds*

Substances

  • Antineoplastic Agents
  • Everolimus